Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 4
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
EpCAMlow Circulating Tumor Cells: Gold in the Waste.
Nicolazzo C, Gradilone A, Loreni F, Raimondi C, Gazzaniga P. Nicolazzo C, et al. Among authors: loreni f. Dis Markers. 2019 Sep 17;2019:1718920. doi: 10.1155/2019/1718920. eCollection 2019. Dis Markers. 2019. PMID: 31636732 Free PMC article. Review.
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer.
Nicolazzo C, Raimondi C, Gradilone A, Emiliani A, Zeuner A, Francescangeli F, Belardinilli F, Seminara P, Loreni F, Magri V, Tomao S, Gazzaniga P. Nicolazzo C, et al. Among authors: loreni f. Cancers (Basel). 2019 Jul 24;11(8):1042. doi: 10.3390/cancers11081042. Cancers (Basel). 2019. PMID: 31344798 Free PMC article.
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer.
Nicolazzo C, Loreni F, Caponnetto S, Magri V, Vestri AR, Zamarchi R, Gradilone A, Facchinetti A, Rossi E, Cortesi E, Gazzaniga P. Nicolazzo C, et al. Among authors: loreni f. Oncotarget. 2020 Nov 10;11(45):4115-4122. doi: 10.18632/oncotarget.27794. eCollection 2020 Nov 10. Oncotarget. 2020. PMID: 33227095 Free PMC article.
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
Nicolazzo C, Busetto GM, Gradilone A, Sperduti I, Del Giudice F, Loreni F, Cortesi E, de Berardinis E, Gazzaniga P, Raimondi C. Nicolazzo C, et al. Among authors: loreni f. Oncologist. 2019 May;24(5):612-616. doi: 10.1634/theoncologist.2018-0784. Epub 2019 Apr 3. Oncologist. 2019. PMID: 30944184 Free PMC article.